000 | 01483 a2200397 4500 | ||
---|---|---|---|
005 | 20250516062533.0 | ||
264 | 0 | _c20120224 | |
008 | 201202s 0 0 jpn d | ||
022 | _a1349-7413 | ||
024 | 7 |
_a10.2177/jsci.34.408 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIshigatsubo, Yoshiaki | |
245 | 0 | 0 |
_a[Behçet's disease from the aspect of autoinflammatory disease]. _h[electronic resource] |
260 |
_bNihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology _c2011 |
||
300 |
_a408-19 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAutoimmunity |
650 | 0 | 4 |
_aBehcet Syndrome _xepidemiology |
650 | 0 | 4 |
_aCytoskeletal Proteins _xgenetics |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aGene-Environment Interaction |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 | _aGenome-Wide Association Study |
650 | 0 | 4 | _aHLA-B51 Antigen |
650 | 0 | 4 |
_aHereditary Autoinflammatory Diseases _xepidemiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterleukin-17 _xphysiology |
650 | 0 | 4 |
_aInterleukin-1beta _xantagonists & inhibitors |
650 | 0 | 4 | _aMolecular Targeted Therapy |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aPyrin |
650 | 0 | 4 |
_aTh17 Cells _ximmunology |
700 | 1 | _aSamukawa, Sei | |
773 | 0 |
_tNihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology _gvol. 34 _gno. 5 _gp. 408-19 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2177/jsci.34.408 _zAvailable from publisher's website |
999 |
_c21272054 _d21272054 |